BridgeMD
New treatment option for Breast Cancer
Official title Impact of Consumption of Ultra-processed Foods in Individuals at High Risk of Cancer
ClinicalTrials.gov ID: NCT07436312
What this study is testing
- What it's testing
- The U-TRANS study was initiated by Gustave Roussy, which is its sponsor\ . It is part of the Interception Program and aims to reduce the consumption of ultra-processed foods in order to improve the overall quality of the diet among people at high risk of cancer (WCRF score ≤ 5, corresponding to low adherence to nutritional cancer prevention recommendations: eating a diet rich in whole grains, vegetables, fruit and fibre, and limiting ultra-processed foods, red meat, processed meats, sugary drinks and alcohol).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age \> 18 years,
- Individuals at increased risk of different cancers as defined within the Interception program,
- With a baseline WCRF score ≤ 5 at entry in the Interception program,
- Agreeing to participate and who have given their written agreement for the study,
- Agreeing to fill in the questionnaires on the dedicated platform for the duration of the study,
You likely can't join if
- Psychiatric disorders or cognitive impairments precluding participation,
- Patient under guardianship or deprived of his liberty by a judicial or administrative decision or incapable of giving its consent.
See the full eligibility criteria
- Age \> 18 years,
- Individuals at increased risk of different cancers as defined within the Interception program,
- With a baseline WCRF score ≤ 5 at entry in the Interception program,
- Agreeing to participate and who have given their written agreement for the study,
- Agreeing to fill in the questionnaires on the dedicated platform for the duration of the study,
- Participant have and accept to use their smartphone,
- All participants must understand spoken and written French language
- Psychiatric disorders or cognitive impairments precluding participation,
- Patient under guardianship or deprived of his liberty by a judicial or administrative decision or incapable of giving its consent.
The study team makes the final eligibility decision.
Where it's taking place
- Avignon, France
- Rennes, France
- Villejuif, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Avignon, France; Rennes, France; Villejuif, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.